Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

3(43%)

Results Posted

33%(1 trials)

Phase Distribution

Ph phase_3

29%

Ph phase_2

14%

Ph phase_1

43%

Ph phase_4

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

3(42.9%)

Phase 2Efficacy & side effects

1(14.3%)

Phase 3Large-scale testing

2(28.6%)

Phase 4Post-market surveillance

1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(3)

Detailed Status

Completed3

Recruiting3

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (42.9%)

Phase 21 (14.3%)

Phase 32 (28.6%)

Phase 41 (14.3%)

Trials by Status

completed343%

not_yet_recruiting114%

recruiting343%

Recent Activity

3 active trials

Showing 5 of 7

recruitingphase_4

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

NCT07160244

completedphase_3

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

NCT03621670

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT05170399Phase 4

Vaccine Responses in Patients With B Cell Malignancies

Recruiting

NCT07712575Phase 1

A Study of V132 in Healthy Older Participants (V132-001)

Not Yet Recruiting

NCT07168915Phase 1

A Study of V118E in Healthy Participants (V118E-003)

Recruiting

NCT07160244Phase 3

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Recruiting

NCT03621670Phase 3

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Completed

NCT06611033Phase 1

A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)

Completed

NCT05412030Phase 2

A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7